IMPLANT360 Trademark
Trademark Overview
On Wednesday, March 8, 2023, a trademark application was filed for IMPLANT360 with the United States Patent and Trademark Office. The USPTO has given the IMPLANT360 trademark a serial number of 97828643. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Wednesday, May 21, 2025. This trademark is owned by HemaTerra Technologies, LLC. The IMPLANT360 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Software as a service (SAAS) services featuring software in the field of managing and monitoring the distribution, inventory and use of medical tissue and devices for use by healthcare providers and healthcare facilities; Software as a service (SAAS) services featuring software in the field of developing and providing predictive analytics to determine best practices and purchasing cadences for medical tissue and devices; Software as a service (SAAS) services featuring software in the field of helping healthcare providers and healthcare facilities track all of their medical tissue and devices to meet FDA, regulatory and warranty requirements; Software as a service (SAAS) services featuring software in the field of collecting, synthesizing, analyzing and providing to third parties cost data, utilization data, and outcome data for medical procedures, physicians, and hospital medical activities; Software as a service (SAAS) services featuring software in the field of developing and providi...
General Information
Serial Number | 97828643 |
Word Mark | IMPLANT360 |
Filing Date | Wednesday, March 8, 2023 |
Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
Status Date | Wednesday, May 21, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Pseudo Mark | IMPLANT THREE SIX ZERO; IMPLANT THREE HUNDRED SIXTY |
Goods and Services | Software as a service (SAAS) services featuring software in the field of managing and monitoring the distribution, inventory and use of medical tissue and devices for use by healthcare providers and healthcare facilities; Software as a service (SAAS) services featuring software in the field of developing and providing predictive analytics to determine best practices and purchasing cadences for medical tissue and devices; Software as a service (SAAS) services featuring software in the field of helping healthcare providers and healthcare facilities track all of their medical tissue and devices to meet FDA, regulatory and warranty requirements; Software as a service (SAAS) services featuring software in the field of collecting, synthesizing, analyzing and providing to third parties cost data, utilization data, and outcome data for medical procedures, physicians, and hospital medical activities; Software as a service (SAAS) services featuring software in the field of developing and providing predictive analytics to select cost-efficient and outcome-efficient medical tissue and devices for specified procedures |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, March 28, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | HemaTerra Technologies, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Baltimore, MD 21230 |
Trademark Events
Event Date | Event Description |
Saturday, March 11, 2023 | NEW APPLICATION ENTERED |
Tuesday, March 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, December 6, 2023 | ASSIGNED TO EXAMINER |
Wednesday, December 6, 2023 | NON-FINAL ACTION WRITTEN |
Wednesday, December 6, 2023 | NON-FINAL ACTION E-MAILED |
Wednesday, December 6, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, January 12, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, January 12, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Saturday, January 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, January 16, 2024 | SUSPENSION LETTER WRITTEN |
Tuesday, January 16, 2024 | LETTER OF SUSPENSION E-MAILED |
Tuesday, January 16, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Wednesday, November 20, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Wednesday, May 21, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |